# Induction Treatment Followed by Immunosuppression Withdrawal in Liver Transplantation: A Comparative Trial

> **NCT00436722** · PHASE2 · TERMINATED · sponsor: **Hospital Clinic of Barcelona** · enrollment: 72 (estimated)

## Conditions studied

- Liver Diseases

## Interventions

- **DRUG:** ATG (Fresenius Biotech)

## Key facts

- **NCT ID:** NCT00436722
- **Lead sponsor:** Hospital Clinic of Barcelona
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-06
- **Primary completion:** 2009-07
- **Final completion:** —
- **Target enrollment:** 72 (ESTIMATED)
- **Why stopped:** Experimental arm (induction + low dose tacrolimus) not effective.
- **Last updated:** 2009-05-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00436722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00436722, "Induction Treatment Followed by Immunosuppression Withdrawal in Liver Transplantation: A Comparative Trial". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00436722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*